Literature DB >> 11279903

Frequency of factor V Leiden in juvenile migraine with aura.

S Soriani1, C Borgna-Pignatti, E Trabetti, A Casartelli, P Montagna, P F Pignatti.   

Abstract

Patients with migraine are known to be at risk for stroke. It has been reported that in a group of patients with cerebral ischemia and the Leiden mutation of factor V, 67% had classical migraine. We have studied the frequency of this mutation in a group of Italian children and adolescents affected by migraine with aura. The Leiden mutation was detected in 2 (3.5%) of 57 patients and in 8 (3.7%) of 219 controls. The 2 patients carrying the mutation had no peculiar characteristics as compared with the rest of the migrainous population. In our study, the frequency of the Leiden mutation in patients was not different from that of controls. These data contrast with those collected in the Finnish population and in a group of northwestern Italian adult patients, but agree with results previously reported from The Netherlands.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 11279903     DOI: 10.1046/j.1526-4610.1998.3810779.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  4 in total

Review 1.  Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects.

Authors:  Simona Sacco; Davide Cerone; Antonio Carolei
Journal:  J Headache Pain       Date:  2008-07-04       Impact factor: 7.277

Review 2.  Current views of the risk of stroke for migraine with and migraine without aura.

Authors:  Tobias Kurth; Hans-Christoph Diener
Journal:  Curr Pain Headache Rep       Date:  2006-06

3.  The primary headaches: genetics, epigenetics and a behavioural genetic model.

Authors:  Pasquale Montagna
Journal:  J Headache Pain       Date:  2008-03-15       Impact factor: 7.277

4.  Genetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genes.

Authors:  Izabela Domitrz; Michalina Kosiorek; Cezary Żekanowski; Anna Kamińska
Journal:  Hum Genomics       Date:  2016-01-08       Impact factor: 4.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.